Click for best price
Chronic Urticaria Or Hives Drug Market Size, Share 2022
Market Analysis and Insights: Global Chronic Urticaria Or Hives Drug Market
The global Chronic Urticaria Or Hives Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Urticaria Or Hives Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Urticaria Or Hives Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Urticaria Or Hives Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Urticaria Or Hives Drug market.
Global Chronic Urticaria Or Hives Drug Scope and Market Size
Chronic Urticaria Or Hives Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chronic Urticaria Or Hives Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Chronic Urticaria Or Hives Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
GDC-0853
GSK-2646264
BF-Derm-1
Bilastine
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
AstraZeneca Plc
Biofrontera AG
ELORAC, Inc.
Faes Farma, SA
Genentech, Inc.
GlaxoSmithKline Plc
J Uriach Y Compania, S.A.
Mabtech Limited
Merck & Co., Inc.
Mycenax Biotech Inc.
Novartis AG
Panacea Biotec Limited
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Chronic Urticaria Or Hives Drug product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Chronic Urticaria Or Hives Drug, with price, sales, revenue, and global market share of Chronic Urticaria Or Hives Drug from 2019 to 2022.
Chapter 3, the Chronic Urticaria Or Hives Drug competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Urticaria Or Hives Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Chronic Urticaria Or Hives Drug market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Urticaria Or Hives Drug.
Chapter 13, 14, and 15, to describe Chronic Urticaria Or Hives Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Chronic Urticaria Or Hives Drug Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Chronic Urticaria Or Hives Drug Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
101 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Chronic Urticaria Or Hives Drug Product Introduction
1.2 Global Chronic Urticaria Or Hives Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Chronic Urticaria Or Hives Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume for the Year 2017-2028
1.3 United States Chronic Urticaria Or Hives Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Chronic Urticaria Or Hives Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Chronic Urticaria Or Hives Drug Sales in Volume for the Year 2017-2028
1.4 Chronic Urticaria Or Hives Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Chronic Urticaria Or Hives Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Chronic Urticaria Or Hives Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Chronic Urticaria Or Hives Drug Market Dynamics
1.5.1 Chronic Urticaria Or Hives Drug Industry Trends
1.5.2 Chronic Urticaria Or Hives Drug Market Drivers
1.5.3 Chronic Urticaria Or Hives Drug Market Challenges
1.5.4 Chronic Urticaria Or Hives Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Chronic Urticaria Or Hives Drug Market Segment by Type
2.1.1 GDC-0853
2.1.2 GSK-2646264
2.1.3 BF-Derm-1
2.1.4 Bilastine
2.1.5 Others
2.2 Global Chronic Urticaria Or Hives Drug Market Size by Type
2.2.1 Global Chronic Urticaria Or Hives Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Chronic Urticaria Or Hives Drug Market Size by Type
2.3.1 United States Chronic Urticaria Or Hives Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Chronic Urticaria Or Hives Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Chronic Urticaria Or Hives Drug Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Chronic Urticaria Or Hives Drug Market Size by Application
3.2.1 Global Chronic Urticaria Or Hives Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Chronic Urticaria Or Hives Drug Market Size by Application
3.3.1 United States Chronic Urticaria Or Hives Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Chronic Urticaria Or Hives Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Chronic Urticaria Or Hives Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Chronic Urticaria Or Hives Drug Competitor Landscape by Company
4.1 Global Chronic Urticaria Or Hives Drug Market Size by Company
4.1.1 Top Global Chronic Urticaria Or Hives Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Chronic Urticaria Or Hives Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2017-2022)
4.2 Global Chronic Urticaria Or Hives Drug Concentration Ratio (CR)
4.2.1 Chronic Urticaria Or Hives Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chronic Urticaria Or Hives Drug in 2021
4.2.3 Global Chronic Urticaria Or Hives Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Chronic Urticaria Or Hives Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Chronic Urticaria Or Hives Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Chronic Urticaria Or Hives Drug Product Type
4.3.3 Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Chronic Urticaria Or Hives Drug Market Size by Company
4.5.1 Top Chronic Urticaria Or Hives Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Chronic Urticaria Or Hives Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Chronic Urticaria Or Hives Drug Sales by Players (2020, 2021 & 2022)
5 Global Chronic Urticaria Or Hives Drug Market Size by Region
5.1 Global Chronic Urticaria Or Hives Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Chronic Urticaria Or Hives Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Chronic Urticaria Or Hives Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Chronic Urticaria Or Hives Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Chronic Urticaria Or Hives Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Chronic Urticaria Or Hives Drug Sales in Value by Region: 2017-2022
5.3.2 Global Chronic Urticaria Or Hives Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.1.2 North America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Chronic Urticaria Or Hives Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Chronic Urticaria Or Hives Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Chronic Urticaria Or Hives Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 AstraZeneca Plc
7.1.1 AstraZeneca Plc Corporation Information
7.1.2 AstraZeneca Plc Description and Business Overview
7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AstraZeneca Plc Chronic Urticaria Or Hives Drug Products Offered
7.1.5 AstraZeneca Plc Recent Development
7.2 Biofrontera AG
7.2.1 Biofrontera AG Corporation Information
7.2.2 Biofrontera AG Description and Business Overview
7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Biofrontera AG Chronic Urticaria Or Hives Drug Products Offered
7.2.5 Biofrontera AG Recent Development
7.3 ELORAC, Inc.
7.3.1 ELORAC, Inc. Corporation Information
7.3.2 ELORAC, Inc. Description and Business Overview
7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 ELORAC, Inc. Chronic Urticaria Or Hives Drug Products Offered
7.3.5 ELORAC, Inc. Recent Development
7.4 Faes Farma, SA
7.4.1 Faes Farma, SA Corporation Information
7.4.2 Faes Farma, SA Description and Business Overview
7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Faes Farma, SA Chronic Urticaria Or Hives Drug Products Offered
7.4.5 Faes Farma, SA Recent Development
7.5 Genentech, Inc.
7.5.1 Genentech, Inc. Corporation Information
7.5.2 Genentech, Inc. Description and Business Overview
7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Genentech, Inc. Chronic Urticaria Or Hives Drug Products Offered
7.5.5 Genentech, Inc. Recent Development
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Corporation Information
7.6.2 GlaxoSmithKline Plc Description and Business Overview
7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Products Offered
7.6.5 GlaxoSmithKline Plc Recent Development
7.7 J Uriach Y Compania, S.A.
7.7.1 J Uriach Y Compania, S.A. Corporation Information
7.7.2 J Uriach Y Compania, S.A. Description and Business Overview
7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Products Offered
7.7.5 J Uriach Y Compania, S.A. Recent Development
7.8 Mabtech Limited
7.8.1 Mabtech Limited Corporation Information
7.8.2 Mabtech Limited Description and Business Overview
7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Mabtech Limited Chronic Urticaria Or Hives Drug Products Offered
7.8.5 Mabtech Limited Recent Development
7.9 Merck & Co., Inc.
7.9.1 Merck & Co., Inc. Corporation Information
7.9.2 Merck & Co., Inc. Description and Business Overview
7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Products Offered
7.9.5 Merck & Co., Inc. Recent Development
7.10 Mycenax Biotech Inc.
7.10.1 Mycenax Biotech Inc. Corporation Information
7.10.2 Mycenax Biotech Inc. Description and Business Overview
7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Products Offered
7.10.5 Mycenax Biotech Inc. Recent Development
7.11 Novartis AG
7.11.1 Novartis AG Corporation Information
7.11.2 Novartis AG Description and Business Overview
7.11.3 Novartis AG Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Novartis AG Chronic Urticaria Or Hives Drug Products Offered
7.11.5 Novartis AG Recent Development
7.12 Panacea Biotec Limited
7.12.1 Panacea Biotec Limited Corporation Information
7.12.2 Panacea Biotec Limited Description and Business Overview
7.12.3 Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Panacea Biotec Limited Products Offered
7.12.5 Panacea Biotec Limited Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Chronic Urticaria Or Hives Drug Industry Chain Analysis
8.2 Chronic Urticaria Or Hives Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Chronic Urticaria Or Hives Drug Distributors
8.3 Chronic Urticaria Or Hives Drug Production Mode & Process
8.4 Chronic Urticaria Or Hives Drug Sales and Marketing
8.4.1 Chronic Urticaria Or Hives Drug Sales Channels
8.4.2 Chronic Urticaria Or Hives Drug Distributors
8.5 Chronic Urticaria Or Hives Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chronic Urticaria Or Hives Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Chronic Urticaria Or Hives Drug Market Trends
Table 3. Chronic Urticaria Or Hives Drug Market Drivers
Table 4. Chronic Urticaria Or Hives Drug Market Challenges
Table 5. Chronic Urticaria Or Hives Drug Market Restraints
Table 6. Global Chronic Urticaria Or Hives Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Chronic Urticaria Or Hives Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Chronic Urticaria Or Hives Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Chronic Urticaria Or Hives Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Chronic Urticaria Or Hives Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Chronic Urticaria Or Hives Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Chronic Urticaria Or Hives Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global Chronic Urticaria Or Hives Drug Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Chronic Urticaria Or Hives Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global Chronic Urticaria Or Hives Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Chronic Urticaria Or Hives Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Chronic Urticaria Or Hives Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Urticaria Or Hives Drug as of 2021)
Table 18. Top Players of Chronic Urticaria Or Hives Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Chronic Urticaria Or Hives Drug Product Type
Table 20. Date of International Manufacturers Enter into Chronic Urticaria Or Hives Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Chronic Urticaria Or Hives Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Chronic Urticaria Or Hives Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Chronic Urticaria Or Hives Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Chronic Urticaria Or Hives Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Chronic Urticaria Or Hives Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Chronic Urticaria Or Hives Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Chronic Urticaria Or Hives Drug Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Chronic Urticaria Or Hives Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Chronic Urticaria Or Hives Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Chronic Urticaria Or Hives Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Chronic Urticaria Or Hives Drug Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Chronic Urticaria Or Hives Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Chronic Urticaria Or Hives Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. AstraZeneca Plc Corporation Information
Table 43. AstraZeneca Plc Description and Business Overview
Table 44. AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. AstraZeneca Plc Chronic Urticaria Or Hives Drug Product
Table 46. AstraZeneca Plc Recent Development
Table 47. Biofrontera AG Corporation Information
Table 48. Biofrontera AG Description and Business Overview
Table 49. Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Biofrontera AG Product
Table 51. Biofrontera AG Recent Development
Table 52. ELORAC, Inc. Corporation Information
Table 53. ELORAC, Inc. Description and Business Overview
Table 54. ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. ELORAC, Inc. Product
Table 56. ELORAC, Inc. Recent Development
Table 57. Faes Farma, SA Corporation Information
Table 58. Faes Farma, SA Description and Business Overview
Table 59. Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Faes Farma, SA Product
Table 61. Faes Farma, SA Recent Development
Table 62. Genentech, Inc. Corporation Information
Table 63. Genentech, Inc. Description and Business Overview
Table 64. Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Genentech, Inc. Product
Table 66. Genentech, Inc. Recent Development
Table 67. GlaxoSmithKline Plc Corporation Information
Table 68. GlaxoSmithKline Plc Description and Business Overview
Table 69. GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. GlaxoSmithKline Plc Product
Table 71. GlaxoSmithKline Plc Recent Development
Table 72. J Uriach Y Compania, S.A. Corporation Information
Table 73. J Uriach Y Compania, S.A. Description and Business Overview
Table 74. J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. J Uriach Y Compania, S.A. Product
Table 76. J Uriach Y Compania, S.A. Recent Development
Table 77. Mabtech Limited Corporation Information
Table 78. Mabtech Limited Description and Business Overview
Table 79. Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Mabtech Limited Product
Table 81. Mabtech Limited Recent Development
Table 82. Merck & Co., Inc. Corporation Information
Table 83. Merck & Co., Inc. Description and Business Overview
Table 84. Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Merck & Co., Inc. Product
Table 86. Merck & Co., Inc. Recent Development
Table 87. Mycenax Biotech Inc. Corporation Information
Table 88. Mycenax Biotech Inc. Description and Business Overview
Table 89. Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Mycenax Biotech Inc. Product
Table 91. Mycenax Biotech Inc. Recent Development
Table 92. Novartis AG Corporation Information
Table 93. Novartis AG Description and Business Overview
Table 94. Novartis AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Novartis AG Product
Table 96. Novartis AG Recent Development
Table 97. Panacea Biotec Limited Corporation Information
Table 98. Panacea Biotec Limited Description and Business Overview
Table 99. Panacea Biotec Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Panacea Biotec Limited Product
Table 101. Panacea Biotec Limited Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Chronic Urticaria Or Hives Drug Customers List
Table 105. Chronic Urticaria Or Hives Drug Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Urticaria Or Hives Drug Product Picture
Figure 2. Global Chronic Urticaria Or Hives Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Chronic Urticaria Or Hives Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global Chronic Urticaria Or Hives Drug Sales 2017-2028 (K Pcs)
Figure 5. United States Chronic Urticaria Or Hives Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Chronic Urticaria Or Hives Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States Chronic Urticaria Or Hives Drug Sales 2017-2028 (K Pcs)
Figure 8. United States Chronic Urticaria Or Hives Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Chronic Urticaria Or Hives Drug Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Chronic Urticaria Or Hives Drug Report Years Considered
Figure 11. Product Picture of GDC-0853
Figure 12. Product Picture of GSK-2646264
Figure 13. Product Picture of BF-Derm-1
Figure 14. Product Picture of Bilastine
Figure 15. Product Picture of Others
Figure 16. Global Chronic Urticaria Or Hives Drug Market Share by Type in 2022 & 2028
Figure 17. Global Chronic Urticaria Or Hives Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Chronic Urticaria Or Hives Drug Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Chronic Urticaria Or Hives Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States Chronic Urticaria Or Hives Drug Market Share by Type in 2022 & 2028
Figure 23. United States Chronic Urticaria Or Hives Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Chronic Urticaria Or Hives Drug Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Chronic Urticaria Or Hives Drug Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Chronic Urticaria Or Hives Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Hospital
Figure 30. Product Picture of Others
Figure 31. Global Chronic Urticaria Or Hives Drug Market Share by Application in 2022 & 2028
Figure 32. Global Chronic Urticaria Or Hives Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Chronic Urticaria Or Hives Drug Sales by Application (2017-2028) & (K Pcs)
Figure 35. Global Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Chronic Urticaria Or Hives Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 37. United States Chronic Urticaria Or Hives Drug Market Share by Application in 2022 & 2028
Figure 38. United States Chronic Urticaria Or Hives Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Chronic Urticaria Or Hives Drug Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Chronic Urticaria Or Hives Drug Sales by Application (2017-2028) & (K Pcs)
Figure 41. United States Chronic Urticaria Or Hives Drug Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Chronic Urticaria Or Hives Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 44. North America Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. Europe Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 55. Asia-Pacific Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 67. Latin America Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Chronic Urticaria Or Hives Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 72. Middle East & Africa Chronic Urticaria Or Hives Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. U.A.E Chronic Urticaria Or Hives Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Chronic Urticaria Or Hives Drug Value Chain
Figure 77. Chronic Urticaria Or Hives Drug Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
